| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Denali Therapeutics Inc. | Director | Common Stock | 10,632 | $154,376 | $14.52 | 04 Nov 2025 | Direct |
| iTeos Therapeutics, Inc. | Director | Common Stock | 22,346 | $96,087 | $4.30 | 13 May 2025 | Direct |
| Denali Therapeutics Inc. | Director | Stock Option (right to buy) | 31,897 | 04 Nov 2025 | Direct | ||
| Lexeo Therapeutics, Inc. | Director | Stock Option (right to buy) | 22,916 | 26 Jun 2025 | Direct | ||
| iTeos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 13 May 2025 | Direct | ||
| RayzeBio, Inc. | Director | Stock Option (Right to Buy) | 0 | 26 Feb 2024 | Direct |